Navigation Links
Venugopal will not be Sacked Before Court Verdict: Central Government

The central government Thursday assured the Delhi High Court that it would not sack All India Institute of Medical Sciences (AIIMS) director P. Venugopal from the post// till the court decided on his petition.

Additional Solicitor General Gopal Subramaniam gave this assurance to the court when counsel for Venugopal, Arun Jaitley, asked for a provision from the court on the government from acting upon the AIIMS governing body's recommendation of Wednesday.

Subramaniam submitted before Justice Anil Kumar that the government would not act upon the recommendation till the court decided on Venugopal's petition.

Venugopal, a renowned cardiologist, moved the high court following the governing body's resolution recommended the government to sack him for "violating the code of conduct".

Subramaniam also suggested to Jaitley to request Venugopal to relinquish the post on his own, following which the governing body would withdraw the recommendation for an amicable solution to the dispute.

Jaitley, however, showed little interest in the compromise formula saying that Venugopal's utmost concern was to protect the autonomy of the prestigious institute and there was no question of considering any out-of-court settlement unless the director's concern was addressed by the court.

Earlier Jaitley said the governing body's recommendation to remove Venugopal was malafide and unlawful as the body was not properly constituted.

He submitted that the health minister and the health secretary were nominated to the body in violation of the All India Institute of Medical Sciences Act.

However, Subramaniam argued that the governing body was in full legal competence to make the recommendation. He said a director of the institute could be removed like any other employee by serving him a three months' notice or three months' salary.

The matter will be heard further Friday.

(Source: IANS)
'"/>




Related medicine news :

1. Venugopal Should Not Have Gone Public: Ramadoss
2. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
3. AIIMS Director Venugopal Sacked
4. Delhi High Court Stays Venugopals Removal
5. Normalcy Returns To AIIMS; Venugopal Attends Office
6. AIIMS Official Files Complaint Against Venugopal
7. AIIMS Director Venugopal Removed from Additional Post
8. Court Issues Notice to Venugopal Over Fund Irregularities
9. Employees Sacked To Tackle Huge Debts Faced By the Hospital
10. AIIMS Director Venugopal Sacked
11. Australian State Health Official Sacked Following Poisoning Outbreak in Nursing Home
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. ... DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig ... Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference ...
(Date:12/8/2016)... ... 2016 , ... SunView Software aims to redefine IT self-service ... engaging and easy to use. Coming off the heels of a successful launch ... plans to roll out new AI-powered self-service enhancements to help organizations implement effective ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016  Axovant Sciences Ltd. (NYSE: ... company focused on the treatment of dementia, today ... a Phase 2b trial evaluating treatment with intepirdine ... with donepezil plus placebo in people with mild-to-moderate ... of intepirdine to treatment was associated with reduced ...
(Date:12/8/2016)... -- KEY FINDINGS ... Patient warming and cooling devices offer ... lowering the risks of neurological disorders post cardiac arrests, rapid ... warming systems can be segmented into convective warming system, surface ... the stay at hospitals thus, lowering the healthcare costs by ...
(Date:12/8/2016)... Inc. (NYSE: DPLO) has been recognized by the Detroit Free ... To learn more about Diplomat,s career opportunities, visit ... ... ... a research firm specializing in organizational health and workplace improvement. The ...
Breaking Medicine Technology: